
© 2024 sharedeals.de
Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
05.03. | Instil Bio Non-GAAP EPS of -$1.82 | ||
04.03. | Instil Bio, Inc. Q4 Loss Declines | ||
04.03. | Instil Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update | Clinical data for AXN-2510/IMM2510 monotherapy in relapsed/refractory NSCLC in China by ImmuneOnco, as well as additional safety data in other solid tumors, anticipated in 1H 2025 Enrollment... ► Artikel lesen | |
04.03. | Instil Bio, Inc. - S-8, Securities to be offered to employees in employee benefit plans | ||
04.03. | Instil Bio, Inc. - 10-K, Annual Report |